EDGAR Filing Documents for 0001193125-15-325848

Form 8-K - Current report:

SEC Accession No. 0001193125-15-325848

Filing Date

2015-09-23

Accepted

2015-09-23 06:12:53

Documents

Period of Report

2015-09-22

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d80943d8k.htm	8-K	17605
2	EX-1.1	d80943dex11.htm	EX-1.1	163695
3	EX-5.1	d80943dex51.htm	EX-5.1	9334
4	EX-99.1	d80943dex991.htm	EX-99.1	3764
5	EX-99.2	d80943dex992.htm	EX-99.2	8395
6	GRAPHIC	g80943img001.jpg	GRAPHIC	6233
	Complete submission text file	0001193125-15-325848.txt		212745

Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016

Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344

Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)